Aadi Bioscience
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $7,212 | $6,179 | $5,353 | $6,326 |
Gross Profit | 6,408 | 5,401 | 4,701 | 5,399 |
EBITDA | -12,461 | -14,475 | -18,181 | -16,168 |
EBIT | -12,508 | -14,524 | -18,231 | -16,212 |
Net Income | -12,546 | -14,583 | -18,289 | -16,268 |
Net Change In Cash | 7,212 | 6,179 | 5,353 | 6,326 |
Free Cash Flow | -20,484 | -9,698 | -20,392 | -10,460 |
Cash | 30,537 | 41,139 | 53,780 | 62,888 |
Basic Shares | 27,041 | 27,010 | 26,980 | 26,965 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $24,354 | $15,216 | $1,000 | $14,000 |
Gross Profit | 21,545 | 13,881 | 724 | 13,824 |
EBITDA | -65,365 | -60,124 | -109,147 | -2,485 |
EBIT | -65,534 | -60,283 | -109,423 | -2,661 |
Net Income | -65,765 | -57,010 | -110,090 | -3,478 |
Net Change In Cash | 24,354 | 15,216 | 1,000 | 14,000 |
Cost of Revenue | 144,534 | 4,080 | ||
Free Cash Flow | -63,635 | -50,084 | -22,469 | -12,701 |
Cash | 62,888 | 39,019 | 148,989 | 4,455 |
Basic Shares | 26,917 | 22,511 | 8,923 | 2,542 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.46 |
2024-06-30 | -$0.54 |
2024-03-31 | -$0.68 |
2023-12-31 | -$0.60 |
